| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tacrolimus Binding Proteins | 27 | 2023 | 41 | 6.310 |
Why?
|
| HSP90 Heat-Shock Proteins | 19 | 2023 | 47 | 4.740 |
Why?
|
| Molecular Chaperones | 16 | 2023 | 61 | 2.970 |
Why?
|
| Receptors, Androgen | 12 | 2019 | 122 | 2.890 |
Why?
|
| Receptors, Glucocorticoid | 7 | 2019 | 31 | 1.750 |
Why?
|
| Receptors, Progesterone | 4 | 2015 | 78 | 1.380 |
Why?
|
| Saccharomyces cerevisiae | 8 | 2019 | 193 | 1.150 |
Why?
|
| Saccharomyces cerevisiae Proteins | 5 | 2014 | 112 | 1.090 |
Why?
|
| Receptors, Steroid | 5 | 2019 | 33 | 0.950 |
Why?
|
| Signal Transduction | 12 | 2019 | 1802 | 0.800 |
Why?
|
| Protein Folding | 5 | 2020 | 121 | 0.780 |
Why?
|
| Zebrafish Proteins | 1 | 2019 | 45 | 0.700 |
Why?
|
| Biological Assay | 2 | 2010 | 56 | 0.700 |
Why?
|
| Receptors, Aryl Hydrocarbon | 3 | 2004 | 45 | 0.680 |
Why?
|
| Protein Binding | 12 | 2023 | 913 | 0.630 |
Why?
|
| Models, Molecular | 7 | 2015 | 751 | 0.620 |
Why?
|
| beta Catenin | 2 | 2015 | 46 | 0.560 |
Why?
|
| Second Messenger Systems | 1 | 2015 | 14 | 0.550 |
Why?
|
| Animals | 29 | 2019 | 14307 | 0.530 |
Why?
|
| Prostatic Neoplasms | 3 | 2015 | 794 | 0.530 |
Why?
|
| Carrier Proteins | 2 | 2014 | 287 | 0.510 |
Why?
|
| Water Pollutants, Chemical | 3 | 2014 | 158 | 0.500 |
Why?
|
| Endocrine Disruptors | 3 | 2014 | 38 | 0.500 |
Why?
|
| Humans | 34 | 2023 | 34853 | 0.440 |
Why?
|
| Immunophilins | 4 | 2023 | 5 | 0.440 |
Why?
|
| Genes, Reporter | 3 | 2015 | 132 | 0.430 |
Why?
|
| Mice | 17 | 2019 | 5668 | 0.400 |
Why?
|
| Multiprotein Complexes | 1 | 2011 | 53 | 0.400 |
Why?
|
| Amino Acid Sequence | 7 | 2015 | 1124 | 0.380 |
Why?
|
| Gene Expression Regulation | 5 | 2011 | 968 | 0.370 |
Why?
|
| Estrogens | 2 | 2014 | 190 | 0.350 |
Why?
|
| Molecular Sequence Data | 6 | 2015 | 1490 | 0.340 |
Why?
|
| Stress, Physiological | 2 | 2023 | 137 | 0.330 |
Why?
|
| Peptidylprolyl Isomerase | 3 | 2023 | 10 | 0.330 |
Why?
|
| HSP70 Heat-Shock Proteins | 4 | 2023 | 45 | 0.330 |
Why?
|
| Mice, Knockout | 9 | 2019 | 897 | 0.310 |
Why?
|
| Binding Sites | 4 | 2015 | 597 | 0.310 |
Why?
|
| Stress, Psychological | 4 | 2014 | 541 | 0.290 |
Why?
|
| beta-Galactosidase | 3 | 2011 | 34 | 0.280 |
Why?
|
| Hela Cells | 3 | 2015 | 344 | 0.260 |
Why?
|
| Molecular Dynamics Simulation | 2 | 2019 | 117 | 0.260 |
Why?
|
| Pituitary-Adrenal System | 2 | 2014 | 36 | 0.230 |
Why?
|
| Adenosine Triphosphate | 1 | 2004 | 180 | 0.230 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 2014 | 49 | 0.230 |
Why?
|
| Financing, Organized | 1 | 2022 | 11 | 0.220 |
Why?
|
| Drug Discovery | 2 | 2015 | 77 | 0.220 |
Why?
|
| Heat-Shock Proteins | 2 | 2012 | 51 | 0.200 |
Why?
|
| Phosphoproteins | 1 | 2002 | 154 | 0.200 |
Why?
|
| Intramolecular Oxidoreductases | 2 | 2011 | 9 | 0.200 |
Why?
|
| Yeasts | 2 | 2011 | 19 | 0.200 |
Why?
|
| Adaptation, Psychological | 2 | 2014 | 358 | 0.190 |
Why?
|
| Protein Structure, Tertiary | 6 | 2014 | 383 | 0.190 |
Why?
|
| Proline-Rich Protein Domains | 1 | 2019 | 7 | 0.180 |
Why?
|
| Small Molecule Libraries | 1 | 2020 | 43 | 0.180 |
Why?
|
| Orphan Nuclear Receptors | 1 | 2019 | 6 | 0.170 |
Why?
|
| Environmental Monitoring | 2 | 2011 | 188 | 0.170 |
Why?
|
| Anilides | 2 | 2017 | 27 | 0.170 |
Why?
|
| Male | 13 | 2017 | 18870 | 0.170 |
Why?
|
| Cyclohexanes | 2 | 2017 | 29 | 0.170 |
Why?
|
| Structure-Activity Relationship | 3 | 2015 | 376 | 0.160 |
Why?
|
| Glucocorticoids | 2 | 2016 | 80 | 0.160 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2015 | 40 | 0.160 |
Why?
|
| Biomedical Research | 1 | 2022 | 371 | 0.160 |
Why?
|
| Fibroblasts | 1 | 2019 | 252 | 0.160 |
Why?
|
| Gene Knockdown Techniques | 2 | 2017 | 161 | 0.150 |
Why?
|
| Cell Line, Tumor | 5 | 2017 | 2128 | 0.150 |
Why?
|
| Estrogen Receptor alpha | 2 | 2015 | 105 | 0.150 |
Why?
|
| Inhibitor of Differentiation Proteins | 1 | 2017 | 28 | 0.150 |
Why?
|
| Androgen Antagonists | 1 | 2015 | 19 | 0.140 |
Why?
|
| Spinal Cord | 1 | 2016 | 85 | 0.140 |
Why?
|
| Protein Conformation | 2 | 2015 | 350 | 0.130 |
Why?
|
| Prostate | 2 | 2015 | 136 | 0.130 |
Why?
|
| Synapsins | 1 | 2014 | 7 | 0.130 |
Why?
|
| Molecular Structure | 2 | 2020 | 467 | 0.130 |
Why?
|
| Protein Transport | 2 | 2017 | 286 | 0.130 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 64 | 0.130 |
Why?
|
| Plasmids | 3 | 2005 | 233 | 0.130 |
Why?
|
| Affinity Labels | 1 | 2014 | 7 | 0.130 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2014 | 65 | 0.130 |
Why?
|
| Transcription Factor RelA | 1 | 2014 | 37 | 0.130 |
Why?
|
| Mutation | 5 | 2014 | 1023 | 0.120 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2014 | 49 | 0.120 |
Why?
|
| Chromatography, Affinity | 1 | 2014 | 64 | 0.120 |
Why?
|
| Lactams, Macrocyclic | 3 | 2013 | 7 | 0.110 |
Why?
|
| Prefrontal Cortex | 1 | 2014 | 133 | 0.110 |
Why?
|
| Neoplasms | 2 | 2014 | 1033 | 0.110 |
Why?
|
| Alternative Splicing | 1 | 2013 | 82 | 0.110 |
Why?
|
| Benzoquinones | 3 | 2013 | 34 | 0.110 |
Why?
|
| Transcriptional Activation | 4 | 2017 | 164 | 0.110 |
Why?
|
| Estradiol | 1 | 2014 | 244 | 0.110 |
Why?
|
| Disease Models, Animal | 2 | 2014 | 1300 | 0.110 |
Why?
|
| Gene Deletion | 3 | 2016 | 156 | 0.110 |
Why?
|
| Neurosecretory Systems | 1 | 2011 | 13 | 0.100 |
Why?
|
| Receptors, Mineralocorticoid | 1 | 2011 | 11 | 0.100 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2011 | 18 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2011 | 126 | 0.100 |
Why?
|
| Immunoblotting | 1 | 2011 | 170 | 0.100 |
Why?
|
| Geologic Sediments | 1 | 2011 | 41 | 0.100 |
Why?
|
| Hippocampus | 1 | 2014 | 546 | 0.100 |
Why?
|
| Fluorescence | 1 | 2011 | 117 | 0.100 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2010 | 249 | 0.100 |
Why?
|
| DNA-Binding Proteins | 1 | 2014 | 522 | 0.090 |
Why?
|
| Drug Design | 1 | 2011 | 154 | 0.090 |
Why?
|
| Cell Proliferation | 2 | 2015 | 1149 | 0.090 |
Why?
|
| Infertility, Male | 1 | 2010 | 44 | 0.090 |
Why?
|
| Homeodomain Proteins | 1 | 2011 | 128 | 0.090 |
Why?
|
| Depressive Disorder | 1 | 2011 | 166 | 0.090 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 445 | 0.090 |
Why?
|
| Chromatography, Liquid | 1 | 2010 | 140 | 0.090 |
Why?
|
| Drug Delivery Systems | 1 | 2011 | 182 | 0.090 |
Why?
|
| Blotting, Western | 3 | 2011 | 834 | 0.090 |
Why?
|
| Transcription Factors | 1 | 2014 | 653 | 0.090 |
Why?
|
| Adenosine Triphosphatases | 2 | 2012 | 78 | 0.080 |
Why?
|
| Microtubules | 1 | 2010 | 113 | 0.080 |
Why?
|
| tau Proteins | 1 | 2010 | 161 | 0.080 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2011 | 984 | 0.080 |
Why?
|
| Phosphothreonine | 1 | 2007 | 5 | 0.080 |
Why?
|
| Structural Homology, Protein | 1 | 2007 | 13 | 0.080 |
Why?
|
| Circular Dichroism | 1 | 2007 | 60 | 0.080 |
Why?
|
| Polymerase Chain Reaction | 2 | 2011 | 430 | 0.080 |
Why?
|
| Steroids | 1 | 2007 | 43 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 1530 | 0.080 |
Why?
|
| Point Mutation | 2 | 2005 | 88 | 0.080 |
Why?
|
| Catalytic Domain | 1 | 2007 | 97 | 0.080 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 756 | 0.080 |
Why?
|
| Recombinant Proteins | 2 | 2010 | 485 | 0.080 |
Why?
|
| Sequence Alignment | 1 | 2007 | 257 | 0.070 |
Why?
|
| Escherichia coli | 2 | 2010 | 436 | 0.070 |
Why?
|
| Mice, SCID | 2 | 2017 | 143 | 0.070 |
Why?
|
| Embryo Implantation | 1 | 2005 | 29 | 0.070 |
Why?
|
| Immunohistochemistry | 3 | 2017 | 859 | 0.070 |
Why?
|
| Uterus | 1 | 2005 | 54 | 0.070 |
Why?
|
| Female | 7 | 2015 | 19873 | 0.070 |
Why?
|
| Genotype | 2 | 2005 | 641 | 0.070 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2017 | 242 | 0.070 |
Why?
|
| Phosphorylation | 1 | 2007 | 878 | 0.060 |
Why?
|
| beta-Naphthoflavone | 1 | 2004 | 1 | 0.060 |
Why?
|
| Quinones | 1 | 2004 | 10 | 0.060 |
Why?
|
| Transformation, Genetic | 1 | 2004 | 19 | 0.060 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 881 | 0.060 |
Why?
|
| Cell Nucleus | 2 | 2017 | 351 | 0.060 |
Why?
|
| Gene Expression Regulation, Fungal | 1 | 2004 | 72 | 0.060 |
Why?
|
| Down-Regulation | 1 | 2005 | 420 | 0.060 |
Why?
|
| Vitellogenins | 2 | 2014 | 4 | 0.060 |
Why?
|
| Cyprinidae | 2 | 2014 | 9 | 0.060 |
Why?
|
| Temperature | 1 | 2004 | 275 | 0.060 |
Why?
|
| Writing | 1 | 2022 | 33 | 0.050 |
Why?
|
| Academies and Institutes | 1 | 2022 | 35 | 0.050 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2022 | 77 | 0.050 |
Why?
|
| Lac Operon | 1 | 2002 | 19 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1268 | 0.050 |
Why?
|
| Corticosterone | 2 | 2011 | 73 | 0.050 |
Why?
|
| Fungal Proteins | 1 | 2002 | 130 | 0.050 |
Why?
|
| Maze Learning | 2 | 2011 | 100 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2003 | 355 | 0.050 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2019 | 58 | 0.040 |
Why?
|
| RNA, Messenger | 2 | 2014 | 1152 | 0.040 |
Why?
|
| Ligands | 1 | 2019 | 317 | 0.040 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2017 | 10 | 0.040 |
Why?
|
| Rats | 2 | 2014 | 3261 | 0.040 |
Why?
|
| Posterior Horn Cells | 1 | 2016 | 2 | 0.040 |
Why?
|
| Flutamide | 1 | 2015 | 7 | 0.030 |
Why?
|
| Dihydrotestosterone | 1 | 2015 | 26 | 0.030 |
Why?
|
| Pharmaceutical Solutions | 1 | 2014 | 5 | 0.030 |
Why?
|
| Injections, Intralesional | 1 | 2014 | 11 | 0.030 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 203 | 0.030 |
Why?
|
| Estrone | 1 | 2014 | 21 | 0.030 |
Why?
|
| Mammary Glands, Human | 1 | 2015 | 39 | 0.030 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2014 | 54 | 0.030 |
Why?
|
| Phenotype | 1 | 2017 | 650 | 0.030 |
Why?
|
| Repetitive Sequences, Amino Acid | 1 | 2014 | 6 | 0.030 |
Why?
|
| Allosteric Regulation | 1 | 2014 | 22 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2014 | 85 | 0.030 |
Why?
|
| Oligopeptides | 1 | 2014 | 97 | 0.030 |
Why?
|
| DNA Methylation | 1 | 2016 | 301 | 0.030 |
Why?
|
| United States | 1 | 2022 | 3894 | 0.030 |
Why?
|
| Behavior, Animal | 1 | 2014 | 304 | 0.030 |
Why?
|
| Nerve Tissue Proteins | 1 | 2015 | 338 | 0.030 |
Why?
|
| Oncogene Protein pp60(v-src) | 1 | 2012 | 8 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 484 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 480 | 0.030 |
Why?
|
| Dexamethasone | 1 | 2011 | 43 | 0.030 |
Why?
|
| Gene Expression | 1 | 2014 | 639 | 0.030 |
Why?
|
| Statistics, Nonparametric | 1 | 2011 | 106 | 0.030 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 550 | 0.030 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2011 | 47 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2017 | 781 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 2012 | 172 | 0.030 |
Why?
|
| Inflammation | 1 | 2016 | 577 | 0.030 |
Why?
|
| Swimming | 1 | 2011 | 37 | 0.030 |
Why?
|
| Exploratory Behavior | 1 | 2011 | 72 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2014 | 285 | 0.020 |
Why?
|
| Water Supply | 1 | 2011 | 54 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 2011 | 152 | 0.020 |
Why?
|
| Agriculture | 1 | 2011 | 45 | 0.020 |
Why?
|
| Locomotion | 1 | 2011 | 91 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2014 | 1349 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 2010 | 15 | 0.020 |
Why?
|
| Cell Line | 1 | 2014 | 1289 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 65 | 0.020 |
Why?
|
| Xenopus | 1 | 2010 | 44 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2010 | 87 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2011 | 528 | 0.020 |
Why?
|
| Linear Models | 1 | 2010 | 253 | 0.020 |
Why?
|
| Oocytes | 1 | 2010 | 143 | 0.020 |
Why?
|
| Emotions | 1 | 2011 | 204 | 0.020 |
Why?
|
| Motor Activity | 1 | 2011 | 393 | 0.020 |
Why?
|
| Transfection | 1 | 2010 | 496 | 0.020 |
Why?
|
| Liver | 1 | 2011 | 447 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2010 | 391 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2007 | 48 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2011 | 638 | 0.020 |
Why?
|
| Selection, Genetic | 1 | 2007 | 42 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2011 | 1442 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2007 | 171 | 0.020 |
Why?
|
| Catalysis | 1 | 2007 | 162 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2010 | 1056 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2010 | 528 | 0.020 |
Why?
|
| Time Factors | 1 | 2011 | 1681 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2007 | 286 | 0.020 |
Why?
|
| Histological Techniques | 1 | 2005 | 14 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2010 | 1422 | 0.020 |
Why?
|
| Blotting, Southern | 1 | 2005 | 66 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 2005 | 125 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 2005 | 139 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 2333 | 0.020 |
Why?
|
| Progesterone | 1 | 2005 | 117 | 0.020 |
Why?
|
| Proline | 1 | 2005 | 37 | 0.020 |
Why?
|
| Chaperonins | 1 | 2004 | 5 | 0.020 |
Why?
|
| Genetic Vectors | 1 | 2005 | 154 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2005 | 149 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 2005 | 197 | 0.020 |
Why?
|
| Substrate Specificity | 1 | 2004 | 186 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2005 | 605 | 0.020 |
Why?
|
| Testis | 1 | 2005 | 185 | 0.020 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2004 | 184 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 2004 | 162 | 0.010 |
Why?
|
| Cell Cycle Proteins | 1 | 2004 | 220 | 0.010 |
Why?
|
| Proteins | 1 | 2004 | 352 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 4012 | 0.010 |
Why?
|
| Adult | 1 | 2011 | 11034 | 0.010 |
Why?
|